APLT
Applied Therapeutics Inc
Halal Rating :
Last Price
$0.62
Last updated:
Market Cap
-
7D Change
-9.8%
1 Year Change
-77.33%
Company Overview
Industries
Exchange
Next Earnings Date
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel therapeutics to treat diseases with high unmet medical needs. The company's primary focus is on developing treatments for galactosemia, diabetic cardiomyopathy, and SORD deficiency. Their lead product candidate is AT-007, which targets galactosemia, a rare genetic metabolic disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Applied Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.